0000899243-20-023394.txt : 20200825 0000899243-20-023394.hdr.sgml : 20200825 20200825194203 ACCESSION NUMBER: 0000899243-20-023394 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200821 FILED AS OF DATE: 20200825 DATE AS OF CHANGE: 20200825 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Serafin Andrew CENTRAL INDEX KEY: 0001821460 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39450 FILM NUMBER: 201133887 MAIL ADDRESS: STREET 1: 630 W. GERMANTOWN PIKE CITY: PLYMOUTH MEETING STATE: PA ZIP: 19462 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Harmony Biosciences Holdings, Inc. CENTRAL INDEX KEY: 0001802665 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 822279923 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 630 W GERMANTOWN PIKE STREET 2: SUITE 215 CITY: PLYMOUTH MEETING STATE: PA ZIP: 19462 BUSINESS PHONE: (484) 539-9800 MAIL ADDRESS: STREET 1: 630 W GERMANTOWN PIKE STREET 2: SUITE 215 CITY: PLYMOUTH MEETING STATE: PA ZIP: 19462 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-08-21 0 0001802665 Harmony Biosciences Holdings, Inc. HRMY 0001821460 Serafin Andrew 630 W. GERMANTOWN PIKE, SUITE 215 PLYMOUTH MEETING PA 19462 0 1 0 0 Chief Business Officer Common Stock 2020-08-21 4 C 0 32214 A 32214 D Common Stock 2020-08-21 4 C 0 6871 A 39085 D Series A Preferred Stock 2020-08-21 4 C 0 207869 0.00 D Common Stock 32214 0 D Series C Preferred Stock 2020-08-21 4 C 0 51681 0.00 D Common Stock 6871 0 D Each share of preferred stock automatically converted on a one-for-one basis into Common stock upon the closing of the Issuer's initial public offering. Includes 7,869 shares received upon the payment of an in-kind dividend on the Series A Preferred Stock on August 21, 2020. Includes 661 shares received upon the payment of an in-kind dividend on the Series C Preferred Stock on August 21, 2020. /s/ Stephanie Wisdo, Attorney-in-fact for Andrew Serafin 2020-08-25